导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.24% | 2768/4773 |
| 近一周 | -1.81% | 2899/5465 |
| 近一月 | -3.48% | 2541/5421 |
| 近一季 | -6.60% | 2471/5231 |
| 近半年 | -2.17% | 2038/4920 |
| 近一年 | 1.42% | 2488/4394 |
| 近两年 | 45.76% | 1642/2954 |
| 近三年 | 27.77% | 1177/2253 |
| 成立以来 | 479.92% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.59% 3297/4961 |
11.97% 2259/5312 |
- - |
- - |
| 2025 | 19.61% 2201/4813 |
-0.97% 2497/3635 |
2.24% 1724/4076 |
17.92% 2396/4524 |
0.17% 2161/4813 |
| 2024 | 16.37% 820/3463 |
2.77% 709/2808 |
-1.20% 976/3014 |
16.62% 1397/3129 |
-1.73% 1810/3463 |
| 2023 | -9.18% 1123/2656 |
4.22% 1017/2280 |
-3.90% 959/2385 |
-2.94% 799/2515 |
-6.58% 1835/2655 |
| 2022 | -19.44% 852/2207 |
-13.91% 871/1919 |
6.67% 637/2016 |
-13.71% 954/2113 |
1.66% 1188/2208 |
| 2021 | -3.55% 911/1822 |
-3.20% 777/1255 |
4.16% 916/1330 |
-5.72% 848/1466 |
1.47% 922/1822 |
| 2020 | 26.48% 604/1250 |
-9.72% 714/1028 |
13.10% 649/1067 |
10.17% 578/1164 |
12.45% 468/1184 |
| 2019 | 35.78% 369/1092 |
26.52% 399/754 |
-0.23% 240/804 |
0.67% 486/850 |
6.84% 537/918 |
| 2018 | -22.78% 258/834 |
- - |
- - |
- - |
-11.81% 354/691 |
| 2017 | 22.18% 153/714 |
- - |
- - |
- - |
- - |
| 2016 | -8.72% 252/605 |
- - |
- - |
- - |
- - |
| 2015 | 6.98% 185/575 |
- - |
- - |
- - |
- - |
| 2014 | 51.12% 78/237 |
- - |
- - |
- - |
- - |
| 2013 | -5.16% 94/186 |
- - |
- - |
- - |
- - |
| 2012 | 8.81% 47/140 |
- - |
- - |
- - |
- - |
| 2011 | -22.95% 53/102 |
- - |
- - |
- - |
- - |
| 2010 | -11.45% 24/58 |
- - |
- - |
- - |
- - |
| 2009 | 91.97% 6/27 |
- - |
- - |
- - |
- - |
| 2008 | -64.36% 21/26 |
- - |
- - |
- - |
- - |
| 2007 | 135.63% 13/22 |
- - |
- - |
- - |
- - |
| 2006 | 119.77% 9/14 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 嘉实沪深300ETF联接A VS. 长安沪深300非周期A(740101) |